FIELD: medicine.
SUBSTANCE: invention represents a method for predicting a risk of schizophrenia involving DNA recovery from biological material and detection of polymorphous loci rs16944 and rs1143634 in interleukin - 1β gene, VNTR and rs9657182 in indolamine-2,3-dioxygenase gene, rs2275163 and rs1053230 in kynurenine-3-monooxygenase (KMO) gene; if observing a complex genotype comprising allele C (rs16944), allele T (rs1143634), allele V1 (VNTR), allele C (rs9657182), allele T (rs2275163) and two alleles G (rs1053230), the risk of schizophrenia is predicted.
EFFECT: higher accuracy and effectiveness of predicting the risk of schizophrenia.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF PARANOID SCHIZOPHRENIA | 2012 |
|
RU2506595C2 |
| MULTIPLEX SET OF MARKERS AS TOOL FOR DEVELOPING GENETIC TESTING OF SUSCEPTIBILITY TO SCHIZOPHRENIA, ALCOHOLISM AND CONNECTION WITH PERSONALITY TRAITS IN YOUNG PEOPLE AND MENTAL ABILITIES IN OLD AGE | 2022 |
|
RU2819816C1 |
| METHOD FOR PREDICTION OF STERILITY IN WOMEN WORKING IN PETROCHEMICAL PRODUCTION | 2008 |
|
RU2386133C1 |
| METHOD FOR PREDICTION OF DEVELOPING OCCUPATIONAL HYPERKERATOSIS IN FIBRE GLASS PRODUCTION WORKERS | 2014 |
|
RU2558041C1 |
| METHOD FOR PREDICTION OF RISK OF THROMBOCYTOPENIA DEVELOPMENT ACCOMPANYING CLINICAL COURSE OF CHRONIC LYMPHATIC LEUKAEMIA | 2012 |
|
RU2508543C1 |
| METHOD FOR PREDICTION OF EFFECTIVENESS OF TREATMENT OF RHEUMATOID ARTHRITIS WITH DRUG OLOKIZUMAB BASED ON GENOTYPING | 2020 |
|
RU2749247C1 |
| IMPROVED METHOD AND KIT FOR DETERMINING SEVERITY AND PROGRESSION LEVEL OF PERIODONTAL DISEASE | 2011 |
|
RU2664431C2 |
| METHOD OF PREDICTING RISK OF DEVELOPMENT OF MYOMATOUS NODES OF LARGE SIZES IN PATIENTS WITH MYOMA | 2016 |
|
RU2616246C1 |
| METHOD OF RISK PREDICTION OF BRONCHIAL ASTHMA | 2006 |
|
RU2324937C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF SCHIZOPHRENIA IN MEN WITH PAROXYSMAL ENDOGENOUS PSYCHOSES MANIFESTING AT AGE FROM 18 TO 25 YEARS | 2018 |
|
RU2685549C1 |
